#METABOLOMICS WORKBENCH kenanazam_20160908_171249_mwtab.txt DATATRACK_ID:729 STUDY_ID:ST000460 ANALYSIS_ID:AN000721 PROJECT_ID:PR000354
VERSION             	1
CREATED_ON             	September 8, 2016, 5:22 pm
#PROJECT
PR:PROJECT_TITLE                 	Effect of ATG7 reconstitution in AGY571 cells
PR:PROJECT_TYPE                  	Amino acid steady-state level analysis
PR:PROJECT_SUMMARY               	AGY571 is a B cell lymphoma isolated from Eu-Myc CD19-Cre;ATG7fl/fl mice. AGY571
PR:PROJECT_SUMMARY               	cells engineered to express rtTA and Dox-inducible GFP or ATG7 were treated with
PR:PROJECT_SUMMARY               	500 ng/mL or 1 ug/mL Doxycycline for 48 hours. Assessing the effects of ATG7
PR:PROJECT_SUMMARY               	reexpression in B cell lymphoma.
PR:INSTITUTE                     	H. Lee Moffitt Cancer Center
PR:DEPARTMENT                    	Tumor Biology
PR:LABORATORY                    	John Cleveland
PR:LAST_NAME                     	Fernandez
PR:FIRST_NAME                    	Mario
PR:ADDRESS                       	12902 Magnolia Drive, MRC 4-West
PR:EMAIL                         	mario.fernandez@moffitt.org
PR:PHONE                         	813-745-5140
PR:FUNDING_SOURCE                	5R01CA154739
#STUDY
ST:STUDY_TITLE                   	Effect of ATG7 reconstitution in AGY571 cells
ST:STUDY_TYPE                    	Cells are treated with vehicle or Doxycycline - to induce expression of GFP or
ST:STUDY_TYPE                    	ATG7
ST:STUDY_SUMMARY                 	AGY571 cells engineered to express Dox-inducible GFP or ATG7 were treated with
ST:STUDY_SUMMARY                 	500 ng/mL or 1 ug/mL Doxycycline for 48 hours. Assessing the effects of ATG7
ST:STUDY_SUMMARY                 	reexpression in B cell lymphoma.
ST:INSTITUTE                     	University of Florida
ST:DEPARTMENT                    	SECIM
ST:LABORATORY                    	John Cleveland
ST:LAST_NAME                     	Fernandez
ST:FIRST_NAME                    	Mario
ST:ADDRESS                       	12902 Magnolia Drive, MRC 4-West
ST:EMAIL                         	mario.fernandez@moffitt.org
ST:PHONE                         	813-745-5140
ST:NUM_GROUPS                    	5
ST:TOTAL_SUBJECTS                	15
ST:STUDY_COMMENTS                	Groups collected in triplicate per time point, either treated or untreated with
ST:STUDY_COMMENTS                	Doxycycline.
#SUBJECT
SU:SUBJECT_TYPE                  	Cells
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:CELL_STRAIN_DETAILS           	AGY571
SU:SUBJECT_COMMENTS              	See study design section for cell number per sample for cell counts
SU:CELL_PRIMARY_IMMORTALIZED     	Immortalized
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	AGY571_GFP	AGY571_001	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=9
SUBJECT_SAMPLE_FACTORS           	AGY571_GFP	AGY571_002	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=9.36
SUBJECT_SAMPLE_FACTORS           	AGY571_GFP	AGY571_003	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=6.705
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_004	Treatment:Vehicle | Dox Concentration:0 ug/mL | Ectopic Gene Expression:None (ATG7-/- backgound)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=8.91
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_005	Treatment:Vehicle | Dox Concentration:0 ug/mL | Ectopic Gene Expression:None (ATG7-/- backgound)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=4.725
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_006	Treatment:Vehicle | Dox Concentration:0 ug/mL | Ectopic Gene Expression:None (ATG7-/- backgound)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=7.74
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_007	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:ATG7	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=7.74
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_008	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:ATG7	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=4.68
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_009	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:ATG7	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=5.31
SUBJECT_SAMPLE_FACTORS           	AGY571_GFP	AGY571_010	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=7.584
SUBJECT_SAMPLE_FACTORS           	AGY571_GFP	AGY571_011	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=7.056
SUBJECT_SAMPLE_FACTORS           	AGY571_GFP	AGY571_012	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=5.16
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_013	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:ATG7	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=8.496
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_014	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:ATG7	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=7.728
SUBJECT_SAMPLE_FACTORS           	AGY571_ATG7	AGY571_015	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:ATG7	Hours=48; Genotype=Eu-Myc ATG7-/-; Cell Count (in millions)=9.264
#COLLECTION
CO:COLLECTION_SUMMARY            	Cells were counted, cells were collected via centrifugation, washed twice with
CO:COLLECTION_SUMMARY            	cold 1x PBS, PBS removed and flash frozen. Pellets were saved at -80 C.
CO:SAMPLE_TYPE                   	Cell
CO:COLLECTION_METHOD             	Pellet
CO:COLLECTION_LOCATION           	Lab
CO:COLLECTION_FREQUENCY          	48 hours after Dox treatment
CO:STORAGE_CONDITIONS            	Pellet at -80C
CO:STORAGE_VIALS                 	1.5 mL microfuge tube
CO:TISSUE_CELL_IDENTIFICATION    	AGY571 cells
#TREATMENT
TR:TREATMENT_SUMMARY             	Cells were treated with vehicle (dH2O) or 500 ng/mL doxycycline.
TR:TREATMENT_COMPOUND            	Doxycycline
TR:TREATMENT_DOSE                	0.5-1.0 ug/mL
TR:TREATMENT_DOSEVOLUME          	5 mL
TR:TREATMENT_DOSEDURATION        	48 hours
TR:TREATMENT_VEHICLE             	dH2O
TR:CELL_GROWTH_CONTAINER         	6-well plate
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Amino acid
SP:SAMPLEPREP_PROTOCOL_FILENAME  	SB_AA_Assay.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Amino Acid
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1290 Infinity
CH:COLUMN_NAME                   	Waters AccQ Tag (100 x 2mm, 1.7um)
CH:METHODS_FILENAME              	SB_AA_Assay.pdf
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:LABORATORY_NAME               	Sanford Burnham
#MS
MS:INSTRUMENT_NAME               	Agilent 6490 QQQ
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	Amino Acids
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS         	nmol/mg protein
MS_METABOLITE_DATA_START
Samples	AGY571_004	AGY571_005	AGY571_006	AGY571_001	AGY571_002	AGY571_003	AGY571_010	AGY571_011	AGY571_012	AGY571_007	AGY571_008	AGY571_009	AGY571_013	AGY571_014	AGY571_015
Factors	Treatment:Vehicle | Dox Concentration:0 ug/mL | Ectopic Gene Expression:None (ATG7-/- backgound)	Treatment:Vehicle | Dox Concentration:0 ug/mL | Ectopic Gene Expression:None (ATG7-/- backgound)	Treatment:Vehicle | Dox Concentration:0 ug/mL | Ectopic Gene Expression:None (ATG7-/- backgound)	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:GFP (ATG7-/-)	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:ATG7	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:ATG7	Treatment:Doxycycline | Dox Concentration:1 ug/mL | Ectopic Gene Expression:ATG7	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:ATG7	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:ATG7	Treatment:Doxycycline | Dox Concentration:500 ng/mL | Ectopic Gene Expression:ATG7
Alanine	1.49	3.07	1.95	1.45	1.53	1.76	1.27	1.26	1.66	1.44	2.30	2.42	1.42	1.65	1.76
Arginine	0.10	0.18	0.15	0.12	0.08	0.10	0.06	0.10	0.12	0.09	0.18	0.17	0.09	0.10	0.08
Asparagine	0.12	0.24	0.14	0.12	0.10	0.17	0.11	0.12	0.15	0.10	0.18	0.18	0.10	0.11	0.10
Aspartate	0.52	1.03	0.60	0.64	0.47	0.78	1.22	1.15	1.61	0.54	0.93	0.91	0.65	0.86	0.77
Glutamate	4.62	9.31	5.55	4.18	4.36	5.80	4.91	6.32	7.98	4.96	9.86	8.52	4.64	5.79	5.78
Glutamine	3.76	8.56	6.03	4.60	4.20	5.85	5.19	5.72	7.48	4.51	5.96	7.83	4.41	4.44	4.69
Glycine	1.22	2.41	1.43	1.07	0.99	1.63	1.07	1.04	1.99	1.38	1.94	2.27	1.18	1.53	1.33
Histidine	0.04	0.11	0.08	0.05	0.07	0.09	0.06	0.06	0.11	0.04	0.07	0.10	0.06	0.07	0.07
Isoleucine	0.09	0.25	0.22	0.13	0.16	0.25	0.17	0.17	0.23	0.11	0.15	0.29	0.17	0.15	0.20
Leucine	0.11	0.29	0.19	0.14	0.16	0.22	0.14	0.17	0.25	0.12	0.18	0.23	0.15	0.17	0.18
Lysine		0.46	0.27	0.19	0.20	0.33						0.34		0.21	
Phenylalanine	0.07	0.22	0.17	0.08	0.12	0.15	0.09	0.11	0.17	0.08	0.14	0.17	0.12	0.13	0.16
Proline	1.08	1.94	1.08	0.88	0.86	1.21	0.63	0.75	0.98	0.96	1.46	1.78	0.80	0.90	0.78
Serine	0.32	0.54	0.33	0.35	0.33	0.51	0.27	0.37	0.64	0.39	0.54	0.58	0.30	0.37	0.37
Threonine	0.87	1.82	1.05	0.90	0.82	0.84	0.86	0.91	1.26	0.85	1.52	1.60	0.82	0.94	0.77
Tryptophan	0.03	0.04	0.04	0.03	0.03	0.05	0.03	0.03	0.04	0.03	0.04	0.05	0.04	0.03	0.03
Tyrosine	0.10	0.32	0.20	0.14	0.17	0.22	0.14	0.17	0.27	0.12	0.18	0.25	0.16	0.18	0.17
Valine		0.39	0.28	0.18	0.22	0.30	0.21		0.29			0.36	0.22	0.23	0.23
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	retention index	quantified m/z	PubChem ID	KEGG ID
Alanine	4.16	260.17	5950
Arginine	2.68	345.21	6322
Asparagine	2.25	303.13	6267
Aspartate	2.99	304.11	5960
Glutamate	3.35	318.11	33032
Glutamine	2.65	317.21	5961
Glycine	2.81	246.08	750
Histidine	2.07	326.21	6274
Isoleucine	8.15	302.21	6306
Leucine	8.26	302.21	6106
Lysine	6.66	487.21	5962
Phenylalanine	8.40	336.21	6140
Proline	4.84	286.16	145742
Serine	2.60	276.11	5951
Threonine	3.74	290.11	6288
Tryptophan	8.54	375.21	6305
Tyrosine	6.66	352.21	6057
Valine	7.09	288.21	6287
METABOLITES_END
#END